Bharat Biotech update the efficacy of Covaxin to 65.2% against the Delta variant – ET HealthWorld

Bharat Biotech update the efficacy of Covaxin to 65.2% against the Delta variant – ET HealthWorld

Commending the investigators from AIIMS on the BBV152 study published in Lancet Infectious Diseases, Bharat…

View More Bharat Biotech update the efficacy of Covaxin to 65.2% against the Delta variant – ET HealthWorld